Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women

By de Lignières B.   de Vathaire F.   Fournier S.   Urbinelli R.   Allaert F.   Le M. G.   Kuttenn F.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 332-340

Informa Healthcare

Access to resources Recommend Favorite

Les anomalies des facteurs de la coagulation n&unknown;influencent pas le pourcentage de naissances vivantes chez les femmes aux antecedents d&unknown;avortement spontane a repetition (Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage) - Howard Carp, M.B., B.S., F.R.C.O.G., Mordechai Dolitzky, M.D., Ilan Tur-Kaspa, M.D., and Aida Inbal, M.D, Fertil Steril 2002;78:58-62

By Palle S.  

Gynecology Obstetrique & Fertilite, Vol. 30, Iss. 11, 2002-11 ,pp. : 927-928

Elsevier

Access to resources Recommend Favorite

Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study

By Dew J. E.   Wren B. G.   Eden J. A.  

Climacteric, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-155

Informa Healthcare

Access to resources Recommend Favorite

Etude cas temoins de l&unknown;effet du traitement hormonal substitutif sur le risque primaire cardiovasculaire chez des femmes bien portantes menopausees (A cross-sectional study of the effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women) - G.M. Prelevic, P. Kwong, D.J. Byrne, I.A. Jagroop, J. Ginsburg, D.P. Mikhailidis, Fertil Steril 2002;77(5):945-51

By Homasson N.  

Gynecology Obstetrique & Fertilite, Vol. 30, Iss. 11, 2002-11 ,pp. : 926-927

Elsevier

Access to resources Recommend Favorite

Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women

By Cerne J. Z.   Ferk P.   Leskosek B.   Gersak K.  

Climacteric, Vol. 14, Iss. 4, 2011-08 ,pp. : 458-463

Informa Healthcare

Access to resources Recommend Favorite